
|Articles|June 1, 2004
Genetic marker method for diabetic retinopathy wins patent
Waltham, MA-Interleukin Genetics Inc. has received a U.S. patent for a method that uses specific genetic markers to identify people with diabetes who are at an increased risk of retinopathy.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
SparingVision completes PRODYGY trial patient dosing with SPVN06
2
American College of Physicians Calls for An End of the Term 'Provider' in Policy Paper
3
PRIMA System: A major step in the battle against GA
4
4DMT completes enrollment in 4FRONT-1, phase 3 trial of 4D-150 in AMD
5




























